BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21734049)

  • 1. Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh): structure of the RING domain of TRIM5alpha.
    Lienlaf M; Hayashi F; Di Nunzio F; Tochio N; Kigawa T; Yokoyama S; Diaz-Griffero F
    J Virol; 2011 Sep; 85(17):8725-37. PubMed ID: 21734049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
    Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
    J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus.
    Kim J; Tipper C; Sodroski J
    J Virol; 2011 Aug; 85(16):8116-32. PubMed ID: 21680520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction.
    Diaz-Griffero F; Qin XR; Hayashi F; Kigawa T; Finzi A; Sarnak Z; Lienlaf M; Yokoyama S; Sodroski J
    J Virol; 2009 Oct; 83(20):10737-51. PubMed ID: 19656869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
    Stremlau M; Perron M; Welikala S; Sodroski J
    J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
    Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J
    J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.
    Roa A; Hayashi F; Yang Y; Lienlaf M; Zhou J; Shi J; Watanabe S; Kigawa T; Yokoyama S; Aiken C; Diaz-Griffero F
    J Virol; 2012 Feb; 86(3):1717-27. PubMed ID: 22114335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
    Wagner JM; Christensen DE; Bhattacharya A; Dawidziak DM; Roganowicz MD; Wan Y; Pumroy RA; Demeler B; Ivanov DN; Ganser-Pornillos BK; Sundquist WI; Pornillos O
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces.
    Zhao G; Ke D; Vu T; Ahn J; Shah VB; Yang R; Aiken C; Charlton LM; Gronenborn AM; Zhang P
    PLoS Pathog; 2011 Mar; 7(3):e1002009. PubMed ID: 21455494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interplay between the B-box 2 and the B30.2(SPRY) domains of TRIM5alpha.
    Li X; Song B; Xiang SH; Sodroski J
    Virology; 2007 Sep; 366(2):234-44. PubMed ID: 17543365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association.
    Li X; Sodroski J
    J Virol; 2008 Dec; 82(23):11495-502. PubMed ID: 18799578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conserved sumoylation consensus site in TRIM5α modulates its immune activation functions.
    Nepveu-Traversy MÉ; Berthoux L
    Virus Res; 2014 May; 184():30-8. PubMed ID: 24583231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha.
    Javanbakht H; Diaz-Griffero F; Stremlau M; Si Z; Sodroski J
    J Biol Chem; 2005 Jul; 280(29):26933-40. PubMed ID: 15897199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
    Langelier CR; Sandrin V; Eckert DM; Christensen DE; Chandrasekaran V; Alam SL; Aiken C; Olsen JC; Kar AK; Sodroski JG; Sundquist WI
    J Virol; 2008 Dec; 82(23):11682-94. PubMed ID: 18799573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhesus monkey TRIM5α SPRY domain recognizes multiple epitopes that span several capsid monomers on the surface of the HIV-1 mature viral core.
    Biris N; Tomashevski A; Bhattacharya A; Diaz-Griffero F; Ivanov DN
    J Mol Biol; 2013 Dec; 425(24):5032-44. PubMed ID: 23886867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp.
    Diaz-Griffero F; Kar A; Lee M; Stremlau M; Poeschla E; Sodroski J
    Virology; 2007 Dec; 369(2):400-10. PubMed ID: 17920096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of RING domain to retrovirus restriction by TRIM5alpha depends on combination of host and virus.
    Maegawa H; Miyamoto T; Sakuragi J; Shioda T; Nakayama EE
    Virology; 2010 Apr; 399(2):212-20. PubMed ID: 20110098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Zn-Binding Domains of TRIM32, the E3 Ubiquitin Ligase Mutated in Limb Girdle Muscular Dystrophy 2H.
    Lazzari E; El-Halawany MS; De March M; Valentino F; Cantatore F; Migliore C; Onesti S; Meroni G
    Cells; 2019 Mar; 8(3):. PubMed ID: 30884854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
    Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM5α and Species Tropism of HIV/SIV.
    Nakayama EE; Shioda T
    Front Microbiol; 2012; 3():13. PubMed ID: 22291694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.